提供学术论文选刊润色服务

医学

返回期刊列表

Review Cycle Records

PHARMACEUTICAL STATISTICS

Wiley SCIE 非OA

2026新锐 4区2025中科院 4区2025 JCR Q2

查看审稿周期计算与数据来源报告数据问题

281.6平均天数

249.5中位天数

109最短天数

521最长天数

832025发文量

Paper Review Records

全部论文审稿周期

20 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接

259 天

The Impact of Enrollment Strategies on the Performance of Time‐To‐Event Dose‐Escalation Designs for Phase I Drug Combination Oncology Trials

收稿 2025-12-17 录用 2026-09-02 发表 2026-09-14

作者Xiaowen Tian; Michael Sweeting; Kristine Broglio

作者单位1. Oncology Biometrics, Oncology R&D AstraZeneca Gaithersburg Maryland USA; 2. Oncology Biometrics, Oncology R&D AstraZeneca Cambridge UK

PDF源文件 DOI 网页

247 天

Hierarchical Composite Endpoints for Dose Optimization in Early Phase Oncology Trials

收稿 2025-12-31 录用 2026-09-04 发表 2026-09-13

作者Yuxiang Wu; Xiaohan Guo; Ray Li; Christophe Le Corre

作者单位1. Department of Biostatistics and Bioinformatics Emory University Atlanta Georgia USA; 2. Oncology Biometrics Pfizer New York New York USA

PDF源文件 DOI 网页

521 天

Use of Composite Priors for Assurance of Sequential Therapy Trials: Practical Experiences Using Binary Endpoint Data

收稿 2025-04-02 录用 2026-09-05 发表 2026-09-13

作者Jonathan Wright; Li Ye

作者单位1. GSK London UK; 2. GSK Upper Providence Pennsylvania USA

PDF源文件 DOI 网页

443 天

Applying the Promising Zone Method to Biomarker‐Based Adaptive Designs: A Word of Caution

收稿 2025-06-07 录用 2026-08-24 发表 2026-09-10

作者Jingzhao Wang; Ruobing Li; Jun Zhao; Zhimin Tang; Jianhong Pan

作者单位1. Office of Biostatistics and Clinical Pharmacology, Center for Drug Evaluation National Medical Products Administration Beijing China

PDF源文件 DOI 网页

308 天

Accelerated Stability Studies: A Frequentist–Bayesian Hybrid Simulation Approach Implemented in the AccelStab R Package

收稿 2025-10-15 录用 2026-08-19 发表 2026-09-04

作者Bernard G. Francq; Nikolaos Giannelos; Raymundo Sanchez; Marilena Paludi

作者单位1. GSK Rixensart Belgium; 2. GSK Collegeville Pennsylvania USA; 3. GSK Siena Italy

PDF源文件 DOI 网页

252 天

Robustness of the Pairwise‐Fitting Approach Under Missing at Random Dropout: A Case and Simulation Study

收稿 2025-12-10 录用 2026-08-19 发表 2026-08-28

作者Dries De Witte; Geert Verbeke; Thomas Neyens; Ariel Alonso Abad; Geert Molenberghs

作者单位1. L‐BioStat, KU Leuven Leuven Belgium; 2. I‐BioStat, UHasselt Diepenbeek Belgium

PDF源文件 DOI 网页

190 天

Degrees‐of‐Freedom Approximations for Conditional‐Mean Inference in Random‐Lot Stability Analysis

收稿 2026-02-10 录用 2026-08-19 发表 2026-08-26

作者Andrew T. Karl; Heath Rushing; Richard K. Burdick; Jeff Hofer

作者单位1. Karl Statistical Services LLC Aurora Colorado USA; 2. Adsurgo LLC San Antonio Texas USA; 3. Burdick Statistical Consulting, LLC Colorado Springs Colorado USA; 4. JDH CMC Stats, LLC Avon Indiana USA

PDF源文件 DOI 网页

227 天

Seamless Phase I– II Cancer Clinical Trials Using Kernel‐Based Covariate Similarity

收稿 2025-11-09 录用 2026-06-24 发表 2026-08-21

作者Kana Makino; Natsumi Makigusa; Masahiro Kojima

作者单位1. Department of Data Science for Business Innovation Chuo University Tokyo Japan

PDF源文件 DOI 网页

109 天

A Cautionary Note on Regional Consistency Evaluation With Multiple Primary Endpoints in Multiregional Clinical Trials

收稿 2026-04-13 录用 2026-07-31 发表 2026-08-14

作者Gosuke Homma

作者单位1. Astellas Pharma Inc. Tokyo Japan

PDF源文件 DOI 网页

241 天

Dose Optimization Design for Randomized Phase II Trials With Toxicity and Efficacy Endpoints

收稿 2025-12-03 录用 2026-08-01 发表 2026-08-14

作者Ryuta Tabata; Tomohiro Ohigashi; Takashi Sozu

作者单位1. Department of Information and Computer Technology, Graduate School of Engineering Tokyo University of Science Tokyo Japan; 2. Department of Information and Computer Technology, Faculty of Engineering Tokyo University of Science Tokyo Japan

PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求，转成可验证的期刊方案

说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。

客户询问

我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？

CrushSCI回复

可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议: 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
数据库初筛: Environmental Technology & Innovation

样本口径2026 年最近 5 篇有效论文样本

平均审稿96.4 天

中位数77 天

PHARMACEUTICAL STATISTICS

全部论文审稿周期

The Impact of Enrollment Strategies on the Performance of Time‐To‐Event Dose‐Escalation Designs for Phase I Drug Combination Oncology Trials

Hierarchical Composite Endpoints for Dose Optimization in Early Phase Oncology Trials

Use of Composite Priors for Assurance of Sequential Therapy Trials: Practical Experiences Using Binary Endpoint Data

Applying the Promising Zone Method to Biomarker‐Based Adaptive Designs: A Word of Caution

Accelerated Stability Studies: A Frequentist–Bayesian Hybrid Simulation Approach Implemented in the AccelStab R Package

Robustness of the Pairwise‐Fitting Approach Under Missing at Random Dropout: A Case and Simulation Study

Degrees‐of‐Freedom Approximations for Conditional‐Mean Inference in Random‐Lot Stability Analysis

Seamless Phase I– II Cancer Clinical Trials Using Kernel‐Based Covariate Similarity

A Cautionary Note on Regional Consistency Evaluation With Multiple Primary Endpoints in Multiregional Clinical Trials

Dose Optimization Design for Randomized Phase II Trials With Toxicity and Efficacy Endpoints

把投稿要求，转成可验证的期刊方案

联系 CrushSCI

扫码添加微信好友

正在维护

PHARMACEUTICAL STATISTICS

全部论文审稿周期

The Impact of Enrollment Strategies on the Performance of Time‐To‐Event Dose‐Escalation Designs for Phase I Drug Combination Oncology Trials

Hierarchical Composite Endpoints for Dose Optimization in Early Phase Oncology Trials

Use of Composite Priors for Assurance of Sequential Therapy Trials: Practical Experiences Using Binary Endpoint Data

Applying the Promising Zone Method to Biomarker‐Based Adaptive Designs: A Word of Caution

Accelerated Stability Studies: A Frequentist–Bayesian Hybrid Simulation Approach Implemented in the AccelStab R Package

Robustness of the Pairwise‐Fitting Approach Under Missing at Random Dropout: A Case and Simulation Study

Degrees‐of‐Freedom Approximations for Conditional‐Mean Inference in Random‐Lot Stability Analysis

Seamless Phase I– II Cancer Clinical Trials Using Kernel‐Based Covariate Similarity

A Cautionary Note on Regional Consistency Evaluation With Multiple Primary Endpoints in Multiregional Clinical Trials

Dose Optimization Design for Randomized Phase II Trials With Toxicity and Efficacy Endpoints

相关榜单与期刊入口